Results 1 to 2 of 2

Thread: Artificial oxygen carriers as an alternative to red blood cell transfusion

  1. #1
    Managing Editor Jan B. Wade's Avatar
    Join Date
    Apr 1996
    Location
    Bellingham, Washington, United States
    Posts
    1,591

    Artificial oxygen carriers as an alternative to red blood cell transfusion




    http://www.ncbi.nlm.nih.gov/entrez/q...390&query_hl=1

    Anaesthesist. 2005 Aug;54(8):741-54.






    [Artificial oxygen carriers as an alternative to red blood cell transfusion]

    [Article in German]

    Habler O, Pape A, Meier J, Zwissler B.

    Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Johann Wolfgang Goethe-Universitat, Frankfurt a. M. habler@em.uni-frankfurt.de

    The expected cost-explosion in transfusion medicine (increasing imbalance between donors and recipients, treatment of transfusion-associated complications) increases the socio-economic significance of the development of safe and effective synthetic oxygen carriers as an alternative to the transfusion of allogeneic red blood cells. Currently two types of artificial oxygen carriers have been tested for safety and efficacy in cases of severe anemia otherwise requiring transfusion. Solutions based on human or bovine hemoglobin (HBOC) possess vasoconstrictor properties in addition to their oxygen transport capacity. The impact of vasoconstriction on tissue perfusion and organ function is however not yet fully understood. Nevertheless, in 2001 the bovine HBOC Hemopure was approved in South Africa for treatment of acutely anemic surgical patients. The purely synthetic perfluorocarbon (PFC) emulsions increase the physically dissolved portion of arterial oxygen content. Due to their particulate nature (emulsion droplets) PFCs may only be infused in low doses to avoid overload and malfunction of phagocytic cells of the reticulo-endothelial system. As part of a multimodal blood conservation program (including normovolemic hemodilution and hyperoxia) the low-dose administration of Oxygent effectively increases intraoperative anemia tolerance. Although reduction of perioperative allogeneic blood transfusion has already been demonstrated for HBOC and PFC, the global clinical establishment of artificial oxygen carriers is not to be expected in the near future.

    PMID: 16021390 [PubMed - in process]
    Mr. Jan B. Wade
    Admin
    Email

    Click here for the Best Questions and Answers regarding Transfusion Alternatives and Patient Blood Management.




  2. New Feature! NoBlood Answers!

    • ASK questions regarding Transfusion Alternatives and Patient Blood Management.
    • SHARE your facts, opinions and personal experience.
    • DISCOVER the best answers chosen by Healthcare Professionals and the Public.
    • RANK the best answers.

    Click here to see the Best Answers to Top Questions.

  3. #2
    Registered User
    Join Date
    Jun 2005
    Posts
    3
    Has Oxygent received FDA approval? OR Has Polyheme been approved as yet? Last I heard they were going through phase 111 trials.
    Milton Martinez

Similar Threads

  1. Replies: 1
    Last Post: 04-09-2012, 04:55 PM
  2. Hemoglobin-based oxygen carriers
    By mycues in forum Ask a Professional
    Replies: 1
    Last Post: 02-28-2006, 01:44 PM
  3. Oxygen carriers coursing through clinical trials
    By Jan B. Wade in forum News and Hot Topics such as Hepatitis C, SARS and AIDS
    Replies: 0
    Last Post: 11-14-2005, 10:01 PM
  4. Targeted Oxygen Delivery: A New Alternative to Red Cell Transfusion
    By Nika in forum Medical Articles and Abstracts
    Replies: 0
    Last Post: 03-29-2005, 12:44 AM

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •